Custom Search

Brand Name(s): Fludara
CAS nº: 75607-67-9
(flu dah rah been)

What is Fludarabine?

Fludarabine is a cancer (antineoplastic) medication. It is used to treat chronic lymphocytic leukemia (CLL), a type of blood cancer. It is more commonly known by its brand name, Fludara®.

Fludarabine belongs to the group of medicines called antimetabolites. These type of medications work by interfering with the genetic material (DNA) inside the cancer cells and prevent them from further dividing and growing into more cancer cells.

See more Product Info

Latest News

Xanthus Announces Oral Fludarabine NDA Accepted for Review by U.S. FDA

Xanthus Pharmaceuticals, Inc., a privately-held oncology and autoimmune disease drug development...

[more]

Protherics and Advancell start Acadra(TM) clinical study in B-cell chronic lymphocytic leukaemia

Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused...

[more]

Nipent®, Cytoxan® and Rituxan® Effective for Untreated Poor Risk CLL

Researchers from Ohio State University and the Mayo Clinic have reported that the treatment...

[more]

Use of this site is subject to the following terms of use